Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Sinovac Biotech Current Ratio 2006-2020 | SVA

For a detailed definition, formula and example for Current Ratio, check out our new background page here.
Sinovac Biotech current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Sinovac Biotech Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-12-31 $1.56B $0.68B 2.30
2020-09-30 $0.43B $0.19B 2.19
2020-06-30 $0.34B $0.11B 2.98
2020-03-31 $0.33B $0.08B 4.05
2019-12-31 $0.35B $0.09B 4.01
2019-09-30 $0.31B $0.07B 4.22
2019-06-30 $0.30B $0.07B 4.35
2019-03-31 $0.28B $0.06B 5.01
2018-12-31 $0.28B $0.06B 4.88
2018-09-30 $0.21B $0.08B 2.54
2018-06-30 $0.00B 0.00
2018-03-31 $0.00B 0.00
2016-12-31 $0.13B $0.07B 1.97
2016-09-30 $0.13B $0.07B 1.91
2016-06-30 $0.11B $0.05B 2.11
2016-03-31 $0.13B $0.06B 2.21
2015-12-31 $0.13B $0.06B 2.21
2015-09-30 $0.12B $0.05B 2.44
2015-06-30 $0.14B $0.06B 2.24
2015-03-31 $0.13B $0.06B 2.20
2014-12-31 $0.16B $0.08B 1.94
2014-09-30 $0.16B $0.07B 2.19
2014-06-30 $0.15B $0.07B 2.28
2014-03-31 $0.16B $0.06B 2.47
2013-12-31 $0.16B $0.05B 3.20
2013-09-30 $0.15B $0.05B 2.87
2013-06-30 $0.14B $0.03B 4.21
2013-03-31 $0.13B $0.03B 3.99
2012-12-31 $0.13B $0.03B 4.19
2012-09-30 $0.12B $0.04B 3.00
2012-06-30 $0.12B $0.04B 3.29
2012-03-31 $0.12B $0.04B 3.52
2011-12-31 $0.13B $0.04B 3.25
2011-09-30 $0.13B $0.04B 3.67
2011-06-30 $0.13B $0.03B 3.86
2011-03-31 $0.14B $0.04B 3.13
2010-12-31 $0.15B $0.05B 3.22
2010-09-30 $0.15B $0.03B 5.51
2010-06-30 $0.15B $0.03B 6.16
2010-03-31 $0.17B $0.04B 4.12
2009-12-31 $0.12B $0.05B 2.37
2009-09-30 $0.10B $0.04B 2.39
2009-06-30 $0.09B $0.04B 2.47
2009-03-31 $0.06B $0.02B 3.00
2008-12-31 $0.06B $0.02B 2.93
2008-09-30 $0.06B $0.02B 3.23
2008-06-30 $0.06B $0.02B 2.55
2008-03-31 $0.05B $0.02B 2.57
2007-12-31 $0.04B $0.02B 1.92
2007-09-30 $0.04B $0.02B 1.75
2006-12-31 $0.02B $0.01B 1.83
2005-12-31 $0.02B $0.01B 1.84
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.642B $0.511B
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $173.588B 53.62
Bristol Myers Squibb (BMY) United States $136.238B 9.07
Amgen (AMGN) United States $124.575B 13.49
CSL (CSLLY) Australia $102.379B 0.00
Gilead Sciences (GILD) United States $89.785B 8.68
BioNTech SE (BNTX) Germany $87.107B 18.80
Regeneron Pharmaceuticals (REGN) United States $69.722B 11.97
Illumina (ILMN) United States $65.576B 74.50
Vertex Pharmaceuticals (VRTX) United States $48.850B 18.98
Biogen (BIIB) United States $44.738B 12.28
BeiGene (BGNE) Cayman Islands $37.507B 0.00
Seagen (SGEN) United States $28.420B 47.92
Genmab (GMAB) Denmark $28.322B 69.55
Genmab (GNMSF) Denmark $27.553B 68.87
Horizon Therapeutics Public (HZNP) Ireland $24.783B 23.49
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.621B 0.00
Bio-Techne Corp (TECH) United States $20.882B 93.91
Exact Sciences (EXAS) United States $18.596B 0.00
Novavax (NVAX) United States $17.693B 0.00
ARGENX SE-ADR (ARGX) Netherlands $17.061B 0.00
Repligen (RGEN) United States $16.850B 128.41
Incyte (INCY) United States $16.781B 39.78
BioMarin Pharmaceutical (BMRN) United States $14.257B 102.32
Guardant Health (GH) United States $13.376B 0.00
QIAGEN (QGEN) Netherlands $12.389B 20.98
Zai Lab (ZLAB) China $12.273B 0.00
Intellia Therapeutics (NTLA) United States $11.559B 0.00
CureVac (CVAC) Germany $10.301B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.489B 24.37
Ascendis Pharma (ASND) Denmark $9.109B 0.00
Mirati Therapeutics (MRTX) United States $8.985B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.829B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.380B 0.00
Vir Biotechnology (VIR) United States $7.124B 0.00
Sarepta Therapeutics (SRPT) United States $6.897B 0.00
Beam Therapeutics (BEAM) United States $6.828B 0.00
Fate Therapeutics (FATE) United States $6.815B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.666B 0.00
Exelixis (EXEL) United States $6.528B 71.45
Denali Therapeutics (DNLI) United States $6.426B 182.17
Legend Biotech (LEGN) United States $6.343B 0.00
Blueprint Medicines (BPMC) United States $6.209B 17.52
Twist Bioscience (TWST) United States $6.001B 0.00
Halozyme Therapeutics (HALO) United States $5.984B 24.44
NeoGenomics (NEO) United States $5.942B 805.33
I-Mab (IMAB) China $5.838B 0.00
AbCellera Biologics (ABCL) $5.674B 0.00
Adaptive Biotechnologies (ADPT) United States $5.595B 0.00
Certara (CERT) United States $5.464B 0.00
Alkermes (ALKS) Ireland $4.858B 143.38
Arvinas (ARVN) United States $4.746B 0.00
Editas Medicine (EDIT) United States $4.314B 0.00
Reata Pharmaceuticals (RETA) United States $4.000B 0.00
Arena Pharmaceuticals (ARNA) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.675B 0.00
Galapagos (GLPG) Belgium $3.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.484B 0.00
Prothena (PRTA) Ireland $3.405B 0.00
Kymera Therapeutics (KYMR) United States $3.213B 0.00
ALX Oncology Holdings (ALXO) United States $3.139B 0.00
Insmed (INSM) United States $3.086B 0.00
Emergent Biosolutions (EBS) United States $3.068B 7.40
Apellis Pharmaceuticals (APLS) United States $2.976B 0.00
Amicus Therapeutics (FOLD) United States $2.932B 0.00
Cytokinetics (CYTK) United States $2.830B 0.00
Intra-Cellular Therapies (ITCI) United States $2.795B 0.00
Heska (HSKA) United States $2.777B 532.37
ACADIA Pharmaceuticals (ACAD) United States $2.683B 0.00
Myriad Genetics (MYGN) United States $2.632B 0.00
Arcus Biosciences (RCUS) United States $2.598B 0.00
Instil Bio (TIL) United States $2.544B 0.00
Celldex Therapeutics (CLDX) United States $2.528B 0.00
Morphic Holding (MORF) United States $2.460B 0.00
Sorrento Therapeutics (SRNE) United States $2.459B 0.00
C4 Therapeutics (CCCC) United States $2.420B 0.00
Ligand Pharmaceuticals (LGND) United States $2.414B 35.30
Vericel (VCEL) United States $2.410B 287.17
Seer (SEER) $2.288B 0.00
Atea Pharmaceuticals (AVIR) United States $2.171B 0.00
Alector (ALEC) United States $2.168B 0.00
Myovant Sciences (MYOV) United Kingdom $2.102B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.097B 35.72
Amarin (AMRN) Ireland $2.036B 515.00
Revance Therapeutics (RVNC) United States $2.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.988B 0.00
Castle Biosciences (CSTL) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.919B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.914B 0.00
Berkeley Lights (BLI) United States $1.819B 0.00
NGM Biopharmaceuticals (NGM) United States $1.781B 0.00
Global Blood Therapeutics (GBT) United States $1.749B 0.00
Inovio Pharmaceuticals (INO) United States $1.712B 0.00
Dynavax Technologies (DVAX) United States $1.709B 0.00
PHARMA MAR SA (PHMMF) Spain $1.699B 0.00
UniQure (QURE) Netherlands $1.696B 5.77
Dicerna Pharmaceuticals (DRNA) United States $1.680B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Codexis (CDXS) United States $1.654B 0.00
MorphoSys AG (MOR) Germany $1.643B 0.00
Nurix Therapeutics (NRIX) United States $1.599B 0.00
Ocugen (OCGN) United States $1.576B 0.00
Bionano Genomics (BNGO) United States $1.552B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.536B 0.00
Kadmon Holdings (KDMN) United States $1.505B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.478B 0.00
Genetron Holdings (GTH) China $1.463B 0.00
MaxCyte (MXCT) United States $1.442B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.434B 0.00
PureTech Health (PRTC) United States $1.413B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.408B 0.00
Inhibrx (INBX) United States $1.403B 0.00
Scholar Rock Holding (SRRK) United States $1.396B 0.00
Sangamo Therapeutics (SGMO) United States $1.388B 0.00
Zealand Pharma (ZEAL) Denmark $1.381B 0.00
Travere Therapeutics (TVTX) United States $1.367B 0.00
Agenus (AGEN) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.343B 0.00
Avid Bioservices (CDMO) United States $1.287B 262.25
Fulcrum Therapeutics (FULC) United States $1.242B 0.00
Bluebird Bio (BLUE) United States $1.238B 0.00
Repare Therapeutics (RPTX) Canada $1.169B 0.00
BioAtla (BCAB) United States $1.168B 0.00
RAPT THERAPTICS (RAPT) United States $1.164B 0.00
Precigen (PGEN) United States $1.132B 0.00
MannKind (MNKD) United States $1.131B 0.00
Northwest Biotherapeutics (NWBO) United States $1.129B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.124B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ImmunityBio (IBRX) United States $1.113B 0.00
Absci (ABSI) United States $1.108B 0.00
IDEAYA Biosciences (IDYA) United States $1.032B 0.00
Nkarta (NKTX) United States $1.030B 0.00
Prometheus Biosciences (RXDX) United States $1.016B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.986B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.963B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.943B 29.22
Immatics (IMTX) Germany $0.921B 0.00
Sutro Biopharma (STRO) United States $0.908B 0.00
Avidity Biosciences (RNA) United States $0.903B 0.00
BeyondSpring (BYSI) United States $0.896B 0.00
VBI Vaccines (VBIV) United States $0.847B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Protagonist Therapeutics (PTGX) United States $0.834B 0.00
Mesoblast (MESO) Australia $0.800B 0.00
Shattuck Labs (STTK) United States $0.799B 0.00
Akoya Biosciences (AKYA) United States $0.780B 0.00
Curis (CRIS) United States $0.777B 0.00
Precision BioSciences (DTIL) United States $0.766B 0.00
Cara Therapeutics (CARA) United States $0.764B 95.31
Amryt Pharma (AMYT) United Kingdom $0.760B 0.00
AnaptysBio (ANAB) United States $0.739B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.734B 0.00
Keros Therapeutics (KROS) United States $0.717B 0.00
Mersana Therapeutics (MRSN) United States $0.710B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.702B 12.79
MiMedx (MDXG) United States $0.688B 0.00
Adagene (ADAG) China $0.663B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.657B 0.00
Cellectis S.A (CLLS) France $0.656B 0.00
Pliant Therapeutics (PLRX) United States $0.656B 0.00
Seres Therapeutics (MCRB) United States $0.653B 0.00
Innate Pharma S.A (IPHA) France $0.641B 0.00
Affimed (AFMD) Germany $0.628B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
Spero Therapeutics (SPRO) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
MeiraGTx Holdings (MGTX) United States $0.599B 0.00
ALBIREO PHARMA (ALBO) United States $0.593B 0.00
Epizyme (EPZM) United States $0.586B 0.00
Ambrx Biopharma (AMAM) United States $0.580B 0.00
VistaGen Therapeutics (VTGN) United States $0.575B 0.00
Clovis Oncology (CLVS) United States $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.572B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.572B 0.00
Bolt Biotherapeutics (BOLT) United States $0.569B 0.00
Gritstone Bio (GRTS) United States $0.569B 0.00
DBV Technologies S.A (DBVT) France $0.562B 0.00
Vaccitech (VACC) United Kingdom $0.549B 0.00
Inventiva S.A (IVA) France $0.537B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.529B 0.00
Selecta Biosciences (SELB) United States $0.512B 0.00
AC Immune SA (ACIU) Switzerland $0.508B 0.00
Verastem (VSTM) United States $0.499B 0.00
Clene (CLNN) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
Bellus Health (BLU) Canada $0.472B 0.00
ChromaDex (CDXC) United States $0.462B 0.00
Compugen (CGEN) Israel $0.459B 0.00
Geron (GERN) United States $0.452B 0.00
Arbutus Biopharma (ABUS) United States $0.431B 0.00
Codiak BioSciences (CDAK) United States $0.427B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.425B 0.00
Oncobiologics (OTLK) United States $0.423B 0.00
Starpharma Holdings (SPHRY) Australia $0.412B 0.00
Cue Biopharma (CUE) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.406B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.406B 0.00
Clearside Biomedical (CLSD) United States $0.403B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 12.09
ZIOPHARM Oncology Inc (ZIOP) United States $0.392B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.390B 0.00
Athenex (ATNX) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.369B 10.07
Aeglea BioTherapeutics (AGLE) United States $0.367B 0.00
Cogent Biosciences (COGT) United States $0.358B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.354B 0.00
Neoleukin Therapeutics (NLTX) United States $0.350B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Fortress Biotech (FBIO) United States $0.339B 0.00
Prima BioMed (IMMP) Australia $0.334B 0.00
Opthea (OPT) Australia $0.333B 0.00
Athersys (ATHX) United States $0.333B 0.00
INmune Bio (INMB) United States $0.327B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.318B 0.00
Syros Pharmaceuticals (SYRS) United States $0.315B 0.00
Angion Biomedica (ANGN) United States $0.313B 0.00
AquaBounty Technologies (AQB) United States $0.313B 0.00
XOMA (XOMA) United States $0.290B 122.19
WAVE Life Sciences (WVE) Singapore $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Beyond Air (XAIR) United States $0.278B 0.00
Checkpoint Therapeutics (CKPT) United States $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Kaleido Biosciences (KLDO) $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.247B 0.00
Kamada (KMDA) Israel $0.239B 19.89
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
Adicet Bio (ACET) United States $0.229B 0.00
OVID THERAPEUTC (OVID) United States $0.229B 2.01
Adverum Biotechnologies (ADVM) United States $0.227B 0.00
Trevena (TRVN) United States $0.224B 0.00
Seelos Therapeutics (SEEL) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.203B 0.00
TELA Bio (TELA) United States $0.197B 0.00
NextCure (NXTC) United States $0.193B 0.00
ObsEva SA (OBSV) Switzerland $0.192B 0.00
Talis Biomedical (TLIS) United States $0.185B 0.00
OSMOTICA PHARM (OSMT) United States $0.180B 0.00
SESEN BIO, INC (SESN) United States $0.178B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.177B 0.00
HOOKIPA Pharma (HOOK) United States $0.176B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71
ATyr Pharma (LIFE) United States $0.174B 0.00
Synlogic (SYBX) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.171B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Galena Biopharma (SLS) United States $0.167B 0.00
Erytech Pharma SA (ERYP) France $0.164B 0.00
Catalyst Biosciences (CBIO) United States $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Leap Therapeutics (LPTX) United States $0.158B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
Dyadic (DYAI) United States $0.151B 0.00
LogicBio Therapeutics (LOGC) United States $0.150B 0.00
TScan Therapeutics (TCRX) United States $0.150B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Novogen (KZIA) Australia $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Cyclerion Therapeutics (CYCN) United States $0.135B 0.00
X4 Pharmaceuticals (XFOR) United States $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
Exicure (XCUR) United States $0.124B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.122B 0.00
Abeona Therapeutics (ABEO) United States $0.121B 0.00
Voyager Therapeutics (VYGR) United States $0.118B 6.76
Eyenovia (EYEN) United States $0.117B 0.00
Entera Bio (ENTX) Israel $0.114B 0.00
Yumanity Therapeutics (YMTX) United States $0.114B 0.00
Viridian Therapeutics (VRDN) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Pluristem Therapeutics (PSTI) Israel $0.096B 0.00
Aadi Bioscience (AADI) United States $0.093B 0.00
Celsion (CLSN) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.084B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Statera Biopharma (STAB) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Liminal BioSciences (LMNL) Canada $0.081B 0.00
Aytu BioPharma (AYTU) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Evogene (EVGN) Israel $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.078B 0.00
Advaxis (ADXS) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.076B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.070B 0.00
Longeveron (LGVN) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
Celyad SA (CYAD) Belgium $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Antibe Therapeutics (ATBPF) Canada $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 1.10
BioCardia (BCDA) United States $0.052B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Forte Biosciences (FBRX) United States $0.051B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
ARIDIS PHARMACT (ARDS) United States $0.049B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.035B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.032B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
ZIVO Bioscience (ZIVO) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00